Questioning the value of margin status in treated cervical precancer

Research output: Contribution to journalComment/debatepeer-review

4 Citations (Web of Science)


Cervical carcinoma is the third most common cancer in women worldwide, with more than 500 000 diagnoses and 250 000 deaths annually.1 Persistent infection with human papillomavirus (HPV) can lead to high-grade neoplastic changes (cervical intraepithelial neoplasia [CIN]) that, if untreated, can progress to invasive disease within 10–15 years.2 Knowledge of cervical cancer pathogenesis and the natural history of its precursor lesion (CIN grade 3 [CIN3]) together with a suitable test (the Papanicolaou smear) and excisional treatments, has led to the implementation of successful screening programmes in many countries.
Original languageEnglish
Pages (from-to)1565–1566
Number of pages2
JournalThe Lancet Oncology
Issue number12
Publication statusPublished - Dec 2017


Dive into the research topics of 'Questioning the value of margin status in treated cervical precancer'. Together they form a unique fingerprint.

Cite this